v3.26.1
Income Taxes - Summary of Major Components of Company's Deferred Tax Assets (Detail) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 98,463 $ 85,686
Research and development credit carryforwards 12,357 12,767
Capitalized research and development costs 1,366 13,449
Stock compensation 674 3,570
Other 1,546 306
Total deferred tax assets 114,406 115,778
Valuation allowance (113,743) (115,532)
Deferred tax assets, net of valuation allowance 663 246
Right-of-use assets (654) (246)
Other (9) 0
Total deferred tax liabilities (663) (246)
Net deferred tax assets (liabilities) $ 0 $ 0